New Discoveries in KCTD7-Related Drug-Resistant Epilepsy
Researchers studied a group of 134 Iranian children who have epilepsy that does not respond well to standard medications.
Plain‑language drug resistant epilepsy research: who benefits from surgery, devices, diets, and emerging treatments.
Researchers studied a group of 134 Iranian children who have epilepsy that does not respond well to standard medications.
A recent study looked at how a high-fat, low-carbohydrate diet, known as the ketogenic diet (KD), affects seizure frequency in children with drug-resistant epilepsy.
A study was conducted to see if a mobile app called “Epilepto” could help children with drug-resistant epilepsy remember to take their medications.
Researchers studied the use of two types of brain monitoring—scalp EEG (scEEG) and stereo EEG (SEEG)—in patients with drug-resistant epilepsy.
Researchers studied a patient with severe muscle weakness, a condition known as arthrogryposis, and epilepsy that did not respond to treatment.
This study looked at how effective the ketogenic diet therapy (KDT) is for children with drug-resistant epilepsy caused by specific genetic mutations.
This study focused on understanding the brain structure in a specific condition called focal cortical dysplasia (FCD), which is a common cause of epilepsy that does not respond well to medication.
Researchers studied children with drug-resistant epilepsy (DRE) to find better ways to predict the success of epilepsy surgery.
Researchers studied the use of magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) as a treatment for children with drug-resistant epilepsy, which means their seizures do not respond to standard medications.